Intermittent Pneumatic Compression in Women With Lipo-lymphedema (Lipedema

Status Completed

Clinical Trial Summary

Lipedema is a connective tissue disorder that affects up to 10% of women. It is characterized by painful, swollen subcutaneous tissue and disproportionate fat accumulation (primarily in the lower limbs, however it can spread to the abdomen and arms). Patients are often not aware they are affected by this disease; rather, they think they are just overweight or obese. Patients with lipedema often feel frustrated and uncomfortable as symptoms such as heaviness, pain, and easy bruising impact quality of life. Affected limbs can become so large and heavy that daily tasks such as walking, cleaning, or shopping become impossible. There is currently no cure for lipedema, thus treatment focuses on symptom management and improved patient-reported outcomes. At present, the two main courses of treatment include non-surgical conservative treatment (e.g., Comprehensive Decongestive Therapy (CDT), diet, exercise, emotional/psychological/social support) and lymph-sparing liposuction performed by a surgeon trained in lipedema treatment. The primary goals for treatment include: reduction/elimination of inflammation, swelling, and pain; increase in lymphatic flow, which reduces/eliminates excessive fluid and swelling; overall management of the physical impact of lipedema; and quality of life improvements which can include emotional, psychological/mental, spiritual, and social enhancement in addition to physical management. Intermittent Pneumatic Compression (IPC) devices are often used as home-therapy to treat secondary lymphedema or lipo-lymphedema (lipedema with swelling) and may be helpful in preventing the progression of lipedema. IPC use moves lymphatic fluid and supports the elimination of proteinaceous fluids, thus leading to improved patient-reported symptoms, decreased limb girth and volume, increased elasticity of tissues, and fewer episodes of infection. The purpose of this study is to assess whether 3-4 weeks of IPC usage is associated with alleviation of symptoms and improvement in quality of life in women with lipo-lymphedema (lipedema with swelling).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04213989
Study type	Interventional
Source	Tactile Medical
Contact
Status	Completed
Phase	N/A
Start date	January 31, 2020
Completion date	November 24, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04492046` - Complex Decongestive Applications in Patients With Lipedema
Completed	`NCT04643392` - Physiotherapy Applications in Upper Extremity Lipedema
Recruiting	`NCT05464927` - Visualizing Vascular Mechanisms of Lipedema
Completed	`NCT02907411` - Quadrivas Therapy® to Reduce Lipedema Subcutaneous Adipose Tissue (QUADRIVAS)	N/A
Completed	`NCT06238791` - Plantar Pressure Analysis and Foot Biomechanics in Lipedema and Chronic Venous Disease
Completed	`NCT03758651` - Williams Syndrome Strength, Hormones, Activity & Adiposity, DNA Programming, Eating Study
Completed	`NCT03710798` - Effect of an Low Carbon High Fat Diet on Pain- and Quality of Life in Patients With Lipedema	N/A
Not yet recruiting	`NCT04166084` - Trunk Stabilization Exercises at Lipoedema Patients	N/A
Recruiting	`NCT05628948` - Vascular Lab Resource (VLR) Biorepository
Completed	`NCT05616962` - Collected Data of Medical Food, Vasculera or Diosmiplex, in Clinic Patients 20 to 70 Years Old Diagnosed With Lipedema	N/A
Active, not recruiting	`NCT04632810` - Effect of Ketosis on Pain and Quality of Life in Patients With Lipedema	N/A
Not yet recruiting	`NCT05944796` - Diathermy Effectiveness in Reducing Subcutaneous Adipose Tissue Affected by Lipedema	N/A
Recruiting	`NCT05284266` - The National Lipedema Study	N/A
Active, not recruiting	`NCT06338059` - Relationship Between Vitamin D and Vitamin B12 Levels and Neuropathic Pain in Lipedema
Completed	`NCT04076891` - Treatment of Women With Lipedema Involving Substantial Fat Above the Knee or of Women and Men With Nodular Dercum's Disease	Phase 2
Completed	`NCT03492840` - Treatment of Women With Lipedema Involving Substantial Fat Knee of Women and Men With Nodular Dercum's Disease	Phase 2
Recruiting	`NCT02838277` - Insight Into Subcutaneous Adipose Tissue Disorders	N/A
Completed	`NCT05966779` - Physical Therapy in Lipedema Surgery
Completed	`NCT05488977` - The Effects of Endurance Training on Lipedema	N/A
Enrolling by invitation	`NCT00833599` - Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic Disorders

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Intermittent Pneumatic Compression in Women With Lipo-lymphedema (Lipedema With Swelling)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms